H Lucraft

A population-based study of intensive multi-agent chemotherapy with or without autotransplant for the highest risk Hodgkin's disease patients identified by the Scotland and Newcastle Lymphoma Group (SNLG) prognostic index. A Scotland and Newcastle Lymphoma Group study (SNLG HD III)

S.J. Proctor, M. Mackie, A Dawson et al. · European Journal of Cancer · 2002 · 52 citations

Medicine, Oncology, Chemotherapy +12

Strategic approach to the management of Hodgkin’s disease incorporating salvage therapy with high-dose ifosfamide, etoposide and epirubicin: a Northern Region Lymphoma Group study (UK)

S.J. Proctor, G Jackson, Anne Lennard et al. · Annals of Oncology · 2003 · 38 citations · Full text

Medicine, Oncology, Pharmacotherapy +11

Autologous transplantation in poor risk Hodgkin's disease using high dose melphalan/etoposide conditioning with non-cryopreserved marrow rescue

PRA Taylor, G Jackson, H Lucraft et al. · British Journal of Cancer · 1993 · 28 citations · Full text

Medicine, Hematology, Oncology +11

Follicular dendritic cell tumour in a 9‐year‐old child

E.J. Bradshaw, Katrina Wood, Peter Hodgkinson et al. · Pediatric Blood & Cancer · 2005 · 20 citations

Medicine, Oncology, Surgery +9

Constrictive pericarditis post allogeneic bone marrow transplant for Philadelphia-positive acute lymphoblastic leukaemia

Jim Cavet, Anne Lennard, A. Gascoigne et al. · Bone Marrow Transplantation · 2000 · 19 citations

Medicine, Cardiology, Hematology +14